HOPA

Patrick J. Medina, PharmD, BCOP, is Professor of Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy in Tulsa.
As options for second-line therapy for patients with metastatic renal-cell carcinoma continue to expand, so does the controversy surrounding optimal treatment selection.
As pharmacists’ responsibilities extend beyond dispensing medications to include advanced patient-centered services, many already meet the definition of nonphysician provider under Medicare Part B, yet they are often not reimbursed for their services.
Although beneficence, autonomy, and justice comprise the bulwark of ethical principles in medicine, their prioritization has changed over the course of history.
Page 3 of 3
Results 21 - 24 of 24